Pavel Majer

4.3k total citations · 1 hit paper
117 papers, 3.3k citations indexed

About

Pavel Majer is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pavel Majer has authored 117 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 28 papers in Oncology and 22 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pavel Majer's work include Peptidase Inhibition and Analysis (22 papers), Chemical Synthesis and Analysis (16 papers) and Neuropeptides and Animal Physiology (15 papers). Pavel Majer is often cited by papers focused on Peptidase Inhibition and Analysis (22 papers), Chemical Synthesis and Analysis (16 papers) and Neuropeptides and Animal Physiology (15 papers). Pavel Majer collaborates with scholars based in Czechia, United States and Germany. Pavel Majer's co-authors include Barbara S. Slusher, Jan Konvalinka, Takashi Tsukamoto, Ramnarayan S. Randad, Cyril Bařinka, Rana Rais, Camilo Rojas, Lukáš Tenora, Pavel Šácha and Ajit G. Thomas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Pavel Majer

112 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells

2020 323 citations Liang Zhao, Matthew L. Arwood et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pavel Majer Czechia	31	1.6k	640	565	452	418	117	3.3k
Carston R. Wagner United States	36	2.6k 1.6×	355 0.6×	655 1.2×	221 0.5×	300 0.7×	129	3.8k
Jules A. Shafer United States	44	2.9k 1.8×	600 0.9×	684 1.2×	445 1.0×	196 0.5×	130	6.0k
David L. Selwood United Kingdom	32	1.9k 1.2×	373 0.6×	628 1.1×	223 0.5×	111 0.3×	100	3.7k
Hyo Jin Kang South Korea	32	1.7k 1.1×	476 0.7×	215 0.4×	360 0.8×	178 0.4×	103	2.9k
Jianming Xie United States	30	2.6k 1.6×	517 0.8×	685 1.2×	156 0.3×	346 0.8×	51	4.4k
Jörg Benz Switzerland	34	2.8k 1.8×	296 0.5×	635 1.1×	208 0.5×	689 1.6×	67	4.3k
Michael Hennig Switzerland	38	3.2k 2.0×	735 1.1×	620 1.1×	147 0.3×	915 2.2×	88	4.9k
Luciana Marinelli Italy	43	3.1k 1.9×	912 1.4×	1.2k 2.0×	328 0.7×	473 1.1×	164	5.1k
Olga Perišić United Kingdom	43	6.5k 4.0×	645 1.0×	293 0.5×	299 0.7×	226 0.5×	66	8.3k

Countries citing papers authored by Pavel Majer

Since Specialization

Citations

This map shows the geographic impact of Pavel Majer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Majer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Majer more than expected).

Fields of papers citing papers by Pavel Majer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavel Majer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Majer. The network helps show where Pavel Majer may publish in the future.

Co-authorship network of co-authors of Pavel Majer

This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Majer. A scholar is included among the top collaborators of Pavel Majer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel Majer. Pavel Majer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dračínský, Martin, J. Brynda, Pavel Majer, et al.. (2025). Beyond natural flavonoids: exploring bioisosterism in design and synthesis of influenza endonuclease inhibitors. RSC Medicinal Chemistry. 16(7). 3030–3048.

Li, Yannan, Ajit G. Thomas, A. Sharma, et al.. (2025). Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficits. Neurotherapeutics. 22(6). e00759–e00759.

Sedláĉek, Jindr̂ich, et al.. (2025). Small-molecule activators of NRF1 transcriptional activity prevent protein aggregation. Biomedicine & Pharmacotherapy. 183. 117864–117864. 2 indexed citations

Nedelcovych, Michael T., Ranjeet Prasad Dash, Ying Wu, et al.. (2025). JHU-2545 preferentially shields salivary glands and kidneys during PSMA-targeted imaging. European Journal of Nuclear Medicine and Molecular Imaging. 52(5). 1631–1641. 2 indexed citations

Čermáková, Kateřina, Václav Navrátil, Pavel Majer, et al.. (2024). The evaluation of DNA-linked inhibitor antibody and AlphaScreen assays for high-throughput screening of compounds targeting the cap-binding domain in influenza a polymerase. European Journal of Pharmaceutical Sciences. 205. 106990–106990. 1 indexed citations

Dohnálek, Jan, Jana Škerlová, Stancho Stanchev, et al.. (2024). Extensive targeting of chemical space at the prime side of ketoamide inhibitors of rhomboid proteases by branched substituents empowers their selectivity and potency. European Journal of Medicinal Chemistry. 275. 116606–116606. 2 indexed citations

Novotný, Pavel, Jana Humpolíčková, Stancho Stanchev, et al.. (2024). The zymogenic form of SARS-CoV-2 main protease: A discrete target for drug discovery. Journal of Biological Chemistry. 301(1). 108079–108079.

Ptáček, J., Jiří Schimer, Zsófia Kutil, et al.. (2023). Selectivity of Hydroxamate- and Difluoromethyloxadiazole-Based Inhibitors of Histone Deacetylase 6 In Vitro and in Cells. International Journal of Molecular Sciences. 24(5). 4720–4720. 16 indexed citations

Peters, Diane E., Lukáš Tenora, Xiaolei Zhu, et al.. (2023). A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis. Science Translational Medicine. 15(708). eabn7491–eabn7491. 9 indexed citations

10.

Kugler, Michaël, Rastislav Dzijak, Pavel Srb, et al.. (2022). Identification of specific carbonic anhydrase inhibitors via in situ click chemistry, phage-display and synthetic peptide libraries: comparison of the methods and structural study. RSC Medicinal Chemistry. 14(1). 144–153. 5 indexed citations

11.

Rais, Rana, Kathryn M. Lemberg, Lukáš Tenora, et al.. (2022). Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Science Advances. 8(46). eabq5925–eabq5925. 77 indexed citations

12.

Tumova, Sarka, Magesh Muthu, Roman Tůma, et al.. (2022). Unique peptidic agonists of a juvenile hormone receptor with species-specific effects on insect development and reproduction. Proceedings of the National Academy of Sciences. 119(48). e2215541119–e2215541119. 11 indexed citations

13.

Alt, Jesse, Kathryn M. Lemberg, Arindom Pal, et al.. (2021). Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target Engagement. Current Drug Metabolism. 22(9). 735–745. 3 indexed citations

14.

Neburková, Jitka, Aaron Rulseh, Shery L. Y. Chang, et al.. (2020). Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents. Nanoscale Advances. 2(12). 5567–5571. 14 indexed citations

15.

Barvı́k, Ivan, Petr Heřman, Kateřina Hofbauerová, et al.. (2020). Mapping of CaM, S100A1 and PIP2-Binding Epitopes in the Intracellular N- and C-Termini of TRPM4. International Journal of Molecular Sciences. 21(12). 4323–4323. 7 indexed citations

16.

Lemberg, Kathryn M., Liang Zhao, Ying Wu, et al.. (2019). The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor. Molecular Cancer Therapeutics. 19(2). 397–408. 16 indexed citations

17.

Jirošová, Anna, Andrej Jančařík, Riya C. Menezes, et al.. (2018). Metabolomic and transcriptomic data on major metabolic/biosynthetic pathways in workers and soldiers of the termite Prorhinotermes simplex (Isoptera: Rhinotermitidae) and chemical synthesis of intermediates of defensive (E)-nitropentadec-1-ene biosynthesis. Data in Brief. 18. 1614–1627. 2 indexed citations

18.

Zoll, Sebastian, et al.. (2014). Substrate binding and specificity of rhomboid intramembrane protease revealed by substrate–peptide complex structures. The EMBO Journal. 33(20). 2408–2421. 79 indexed citations

19.

Bařinka, Cyril, Klára Hlouchová, Pavel Majer, et al.. (2008). Structural Basis of Interactions between Human Glutamate Carboxypeptidase II and Its Substrate Analogs. Journal of Molecular Biology. 376(5). 1438–1450. 72 indexed citations

20.

Rojas, Camilo, Ajit G. Thomas, Pavel Majer, et al.. (2005). Glutamate Carboxypeptidase II Inhibition as a Novel Therapeutic Target. Kluwer Academic Publishers eBooks. 524. 205–213. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact